Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome

MONDO:0010295

This syndrome is characterized by severe immunodeficiency, osteopetrosis, lymphedema and anhidrotic ectodermal dysplasia.

Also known as: OL-EDA-ID, ol-EDA-ID, OLEDAID, ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema

5 clinical trials for this condition and its sub-types, 4 tagged with Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Lymphatic malformation (56) ↑ Ectodermal dysplasia syndrome (45) ↑ Osteopetrosis (14) ↑ IKBKG-related immunodeficiency with or without ectodermal dysplasia (4)

Including sub-types (5) Tagged with Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome (4)

Trials to join now! 1 Completed 3

New painkiller oliceridine tested against morphine in back surgery patients

Symptom relief Recruiting now

This study compares a newer painkiller called oliceridine with two standard drugs, morphine and sufentanil, for pain relief after lumbar spine surgery. Ninety adults will receive one of the three drugs through a patient-controlled pump. The main goal is to see how well each drug …

Sponsor: Anqing Municipal Hospital • Aim: Symptom relief

Last updated Jun 27, 2026 13:02 UTC

Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome

Where it sits in the disease tree

New painkiller oliceridine tested against morphine in back surgery patients